Author:
Eloy Catarina,Cameselle-Teijeiro José Manuel,Abdulkader-Nallib Ihab,Amendoeira Isabel,Sobrinho-Simões Manuel
Publisher
Springer Nature Singapore
Reference24 articles.
1. Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022;33:27–63.
2. WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours. Lyon: International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed., vol. 8). https://publications.iarc.fr/610.
3. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol. 2008;36:425–37.
4. Amendoeira I, Maia T, Sobrinho-Simões M. Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): impact on the reclassification of thyroid nodules. Endocr Relat Cancer. 2018;25:R247–58.
5. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676–90.